[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371834-105":59,"doc-detail-371834-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","applications-of-new-generation-sequencing-ngs-in-ocular-oncology","Applications of New Generation Sequencing (NGS) - in Ocular Oncology","","Next-generation sequencing (NGS) has transformed cancer genomics by enabling detailed characterization of the molecular landscape across multiple malignancies, including cancers of the eye. This review summarizes how NGS supports ocular oncology through improved understanding of genetic alterations, discovery of biomarkers, and development of personalized treatment strategies. Applications across uveal melanoma, retinoblastoma, and other ocular tumors—such as ocular adnexa lymphoma and IgG4-related ophthalmic disease—are addressed, alongside key challenges and future directions.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/applications-of-new-generation-sequencing-ngs-in-ocular-oncology/371834/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/applications-of-new-generation-sequencing-ngs-in-ocular-oncology/371834.png","ImageObject",300,407,{"name":92,"@type":93},"Kurz","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",16,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role does NGS play in ocular oncology?","Question",{"text":113,"@type":114},"NGS enables comprehensive genomic profiling of ocular tumors, helping clarify molecular mechanisms, identify biomarkers, and support personalized treatment strategies.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which ocular cancers are discussed for NGS applications?",{"text":118,"@type":114},"The document highlights uveal melanoma, retinoblastoma, ocular adnexa lymphoma, and IgG4-related ophthalmic disease, among other ocular tumors.",{"name":120,"@type":111,"acceptedAnswer":121},"How has sequencing technology evolved for ocular cancer genomics?",{"text":122,"@type":114},"It describes progress from first-generation Sanger sequencing to early NGS platforms for parallel sequencing, and then to third-generation long-read technologies such as PacBio and Oxford Nanopore.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},371834,1790929386,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":19,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":52,"preview_page_count":19,"preview_urls":145},2336478945635,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Applications of New Generation Sequencing (NGS)  \nin Ocular Oncology  \nMizuki Tagami, MD, PhD and Shigeru Honda, MD, PhD  \nAbstract: Next-generation sequencing (NGS) has revolutionized cancer genomics, offering unparalleled insights into the molecular landscape of various malignancies, including ocular cancers. This review explores the role of NGS in ocular oncology, highlighting its impact on understanding genetic alterations, identifying biomarkers, and advancing personalized treatment approaches. Key applications in uveal melanoma, retinoblastoma, and other ocular tumors, including ocular adnexa lymphoma and IgG4-related ophthalmic disease are discussed, along with the challenges and future directions in the ﬁeld. As sequencing technologies continue to evolve, integrating NGS into clinical practice promises to enhance early diagnosis, risk assessment, and therapeutic strategies in ocular oncology.  \nKey Words: RNA-seq, principal component analysis, IgG4-related ophthalmic disease (IgG4-ROD), orbital MALT lymphoma, machine learning, STING, immunohistochemistry (Int Ophthalmol Clin 2025;65:1–4)  \nINTRODUCTION  \nImportance of Genomic Analysis in Ocular Oncology  \nOcular oncology encompasses a wide spectrum of malignancies affecting the eye and its adnexa, including uveal melanoma, retinoblastoma, conjunctival melanoma, and ocular lymphoma. These tumors, while relatively rare,  \nReceived for publication April 30, 2025; accepted July 23, 2025 .  \nFrom the Department of Ophthalmology and Visual Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.  \nThis work was supported by JSPS KAKENHI grant numbers 23K09013 . The sponsor or funding organization had no role in the design or conduct of this research.  \nThe authors declare that they have no conﬂicts of interest to disclose.  \nReprints: Mizuki Tagami, MD, PhD, Department of Ophthalmology and Visual Sciences, Graduate School of Medicine, Osaka Metropolitan University, 1-5-7 Asahimachi, Abeno-ku, Osaka-shi, Osaka 545-8586, Japan (e-mail: [tagami.mizuki@omu.ac.jp](tagami.mizuki@omu.ac.jp)) .  \nCopyright © 2025 The Author(s) . Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.  \nDOI: 10.1097/IIO.0000000000000584  \nInt Ophthalmol Clin 􀀁 Volume 65, Number 4, Fall 2025  \ncan have devastating consequences, including vision loss and metastasis, making accurate diagnosis and effective treatment critical.  \nAdvancements in molecular biology have revealed that many ocular cancers harbor distinct genetic and epigenetic alterations that inﬂuence their pathogenesis, prognosis, and therapeutic response. For instance, uveal melanoma, the most common primary intraocular malignancy in adults, is characterized by driver mutations in GNAQ, GNA11, BAP1, SF3B1, and EIF1AX, which are associated with distinct clinical and prognostic implications. 1,2 Similarly, retinoblastoma, the most common intraocular cancer in children, arises due to biallelic inactivation of the RB1 gene, a tumor suppressor crucial for cell cycle regulation.3,4  \nGenomic analysis has played a pivotal role in identifying these mutations and has facilitated the development of prognostic biomarkers and targeted therapies. Traditional histopathologic approaches provide valuable insights, but they often lack the ability to identify key molecular drivers of disease. With the advent of high-throughput sequencing technologies, particularly next-generation sequencing (NGS), it is now possible to perform comprehensive genomic proﬁling of ocular tumors, leading to a deeper understanding of their molecular underpinnings and paving the way for precision medicine approaches.  \nEvolution of Sequencing","cbCaidubsVqK6We4","https://ap.wps.com/l/cbCaidubsVqK6We4","pdf",246852,"English","# Introduction\n## Importance of Genomic Analysis in Ocular Oncology\n## Evolution of Sequencing Technologies\n# Overview of Next-Generation Sequenc","[{\"question\":\"What role does NGS play in ocular oncology?\",\"answer\":\"NGS enables comprehensive genomic profiling of ocular tumors, helping clarify molecular mechanisms, identify biomarkers, and support personalized treatment strategies.\"},{\"question\":\"Which ocular cancers are discussed for NGS applications?\",\"answer\":\"The document highlights uveal melanoma, retinoblastoma, ocular adnexa lymphoma, and IgG4-related ophthalmic disease, among other ocular tumors.\"},{\"question\":\"How has sequencing technology evolved for ocular cancer genomics?\",\"answer\":\"It describes progress from first-generation Sanger sequencing to early NGS platforms for parallel sequencing, and then to third-generation long-read technologies such as PacBio and Oxford Nanopore.\"}]","Applications of New Generation Sequencing (NGS) - in Ocular Oncology | PDF",1790192981,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96d23dba0cc254454ffd713ae9aae2f1.webp",983,1315,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b94d4e5b5db25a1442ad8d302f61a6e.webp",982,1314,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c0f1f8dbfb8b96847d0541cd2fb5031.webp",981,1312,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1a3e26dadfe0482e117955762b9466d.webp",980,1311]